Early Placebo Improvement Is a Marker for Subsequent Placebo Response in Long-Acting Injectable Antipsychotic Trials for Schizophrenia: Combined Analysis of 4 RCTs

Fumiaki Kumagai, Takefumi Suzuki, W. Wolfgang Fleischhacker, Norio Yasui-Furukori, Masaru Mimura, Hiroyuki Uchida

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Early Placebo Improvement Is a Marker for Subsequent Placebo Response in Long-Acting Injectable Antipsychotic Trials for Schizophrenia: Combined Analysis of 4 RCTs'. Together they form a unique fingerprint.

Medicine & Life Sciences